Ondansetron for hallucinosis in advanced Parkinson's disease
Lancet
.
1993 Feb 27;341(8844):562-3.
doi: 10.1016/0140-6736(93)90327-d.
Authors
J Zoldan
,
G Friedberg
,
H Goldberg-Stern
,
E Melamed
PMID:
8094803
DOI:
10.1016/0140-6736(93)90327-d
No abstract available
Publication types
Clinical Trial
Letter
MeSH terms
Aged
Female
Hallucinations / drug therapy*
Hallucinations / etiology
Humans
Male
Middle Aged
Ondansetron / therapeutic use*
Parkinson Disease / psychology*
Substances
Ondansetron